Drug Facts

Drug Labeling and Warnings

Drug Details [pdf]

LA ROCHE-POSAY LABORATOIRE PHARMACETIQUE HYDRAPHASE UV EYES HYDRATING SPF 29 PROTECTIVE- octinoxate and titanium dioxide lotion 
Laboratoires Industriels de Vichy (LIDV)

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Drug Facts

Active ingredients

Octinoxate 7.5%

Titanium dioxide 5.6%

Uses

  • helps prevent sunburn
  • higher SPF gives more sunburn protection
  • protects against UVA/UVB rays

Directions

  • apply evenly before sun exposure and as needed
  • children under 6 months of age: ask a doctor

Warnings

For external use only

When using this product

keep out of eyes. Rinse with water to remove.

Stop  use and ask a doctor if

rash or irritation develops and lasts

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Inactive ingredients

water, C12-15 alkyl benzoate, isononyl isononanoate, nylon-12, cyclopentasiloxane, alcohol, denat., glycerin, propylene glycol, methylsilanol/silicate crosspolymer, polymethylsilsesquioxane, cetyl PEG/PPG-10/1 dimethicone, PEG-30 dipolyhydroxystearate, synthetic wax, polyglyceryl-4 isostearate, dimethicone, caprylic/acpric triglyceride, polyhydroxystearic acid, cetearyl alcohol, aluminum tristearate, magnesium sulfate, caprylyl glycol, mica, disodium EDTA, alumina, stearalkonium hectorite, dimethiconol, potassium cetyl phosphate, caffeine, capryloyl salicylic acid, propylene carbonate, salicylic acid

image of a label

LA ROCHE-POSAY LABORATOIRE PHARMACETIQUE HYDRAPHASE UV EYES HYDRATING SPF 29 PROTECTIVE 
octinoxate and titanium dioxide lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 66382-157
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate75 mg  in 1 mL
Titanium dioxide (UNII: 15FIX9V2JP) (Titanium dioxide - UNII:15FIX9V2JP) Titanium dioxide56 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
ALKYL (C12-15) BENZOATE (UNII: A9EJ3J61HQ)  
ISONONYL ISONONANOATE (UNII: S4V5BS6GCX)  
NYLON-12 (UNII: 446U8J075B)  
CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)  
ALCOHOL (UNII: 3K9958V90M)  
GLYCERIN (UNII: PDC6A3C0OX)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
POLYMETHYLSILSESQUIOXANE (11 MICRONS) (UNII: Z570VEV8XK)  
CETYL PEG/PPG-10/1 DIMETHICONE (HLB 2) (UNII: V2W71V8T0X)  
PEG-30 DIPOLYHYDROXYSTEARATE (UNII: 9713Q0S7FO)  
SYNTHETIC WAX (1200 MW) (UNII: Q3Z4BCH099)  
POLYGLYCERYL-4 ISOSTEARATE (UNII: 820DPX33S7)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
POLYHYDROXYSTEARIC ACID STEARATE (UNII: 8KQ7I65XZE)  
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
ALUMINUM STEARATE (UNII: U6XF9NP8HM)  
MAGNESIUM SULFATE, UNSPECIFIED FORM (UNII: DE08037SAB)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
MICA (UNII: V8A1AW0880)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
ALUMINUM OXIDE (UNII: LMI26O6933)  
STEARALKONIUM HECTORITE (UNII: OLX698AH5P)  
DIMETHICONOL (70 CST) (UNII: MOT8IL21AR)  
POTASSIUM CETYL PHOSPHATE (UNII: 03KCY6P7UT)  
CAFFEINE (UNII: 3G6A5W338E)  
CAPRYLOYL SALICYLIC ACID (UNII: 5F7PJF6AA4)  
PROPYLENE CARBONATE (UNII: 8D08K3S51E)  
SALICYLIC ACID (UNII: O414PZ4LPZ)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 66382-157-011 in 1 CARTON09/01/200906/01/2012
115 mL in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart35209/01/200906/01/2012
Labeler - Laboratoires Industriels de Vichy (LIDV) (282658798)
Establishment
NameAddressID/FEIBusiness Operations
Laboratoires Industriels de Vichy (LIDV)282658798manufacture(66382-157)

Revised: 8/2019
 

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.